Herbert Michael Heise is Honorary Professor at the University of Applied Sciences of South-Westphalia, Iserlohn and a Senior Scientist at Leibniz-Institute for Analytical Sciences ISAS at Dortmund University of Technology, Germany. Research Fellow at the German National Physical Laboratory (PTB) (1979-1982) and the Federal Biological Research Centre (1977), both in Braunschweig, Germany. Research associate at School of Chemistry, The University of Western Australia, Perth (1976 / 1978-79) and Institute of Physical Chemistry of Christian-Albrechts-University in Kiel, Germany (1974-1976 / 1978) He has received a PhD in Physical Chemistry (1976), completed his Diploma Degree in Chemistry (M.Sc., 1972) and received a B.Sc. equivalent degree in mathematics (1974) from Kiel University. Gledden Visiting Senior Fellow at The University of Western Australia (2003). Honorary Fellow of the Association of Biotechnology and Pharmacy (2009). He is serving as a member of the editorial board of Vibrational Spectroscopy and Current Trends in Biotechnology and Pharmacy ; he is reviewer of more than 5 other journals in the area of analytical chemistry and spectroscopy. He is co-author of two textbooks and of 180 publications including contributions to book chapters and encyclopedias.
1. How many years have you been associated with the current research?
For 30 years I am now with research for diabetes technology, mainly in the area of glucose sensor technology based on molecular spectroscopy (non-invasive, minimal invasive and continuous glucose monitoring for artificial pancreas development).
2. What is the research topic you are working on now?
Continuous blood glucose monitoring using infrared spectroscopy using FT spectrometers and novel tuneable quantum cascade lasers for device miniaturization. Further research is in fiber-optics based sensor technology.
3. What are attributes for a quality article?
Novelty, clarity of presentation including concise language and impressive and readable graphics. The state of the art for the paper subject must be clearly presented with relevant literature citations listed.
4. Do you have any research funding (NIH or other national funding) now?
A 3-year project funded by the German Federal Ministry of Research and Education for novel sensor technology for continuous blood glucose monitoring based on quantum cascade lasers (QCLs) with a start in September, 2013.
5. When did you become an editor of OMICS Journal?
On the occasion of my participation in the International Conference on Diabetes & Metabolism, Santa Clara, CA, USA, December, 2010
6. Where can the journal find the maximum scope in terms of niche?
My suggestions are epidemiological studies, nutritional aspects, diagnostics with regard to screening of diabetes and diabetes therapy technology for improved long-term outcome (also individual elements of an artificial pancreas system), FDA regulation reports
7.What is your greatest career accomplishment?
Our feasibility study on the realisation of non-invasive blood glucose measurement technology using near-infrared spectroscopy of lip tissue; further achievements are in minimal-invasive testing using nanoliter body fluid samples and most reliable spectrometric sensor technology for reagent-free continuous multi-analyte monitoring for critically ill patients (e.g., glucose, lactate, urea, pCO2 and others).
8. How does the published scientific content assist the potential researchers?
The peer-reviewed literature is our main data base and the speed of publication nowadays leads to only short delays when compared to reports and presentations from national and international conferences; review articles and text books allow for a fast introduction to the field of research for young researchers.
9. What is the purpose of serving as an editor?
Supporting the scientific community with my expertise and knowledge for advancing our medical and biochemical understanding of the emergence and treatment of diseases, especially diabetes; I hope that assisting authors with constructive criticism will improve the quality of publications. Avoiding plagiarism and the inflationary trend of repeated result presentation in bits and pieces are another aspect for the task of an editor.
10. Do you have any patents?
Yes, for spectroscopic sensor technology.
11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
13.How would you define your experience with OMICS Group?
I am also an editor for an Elsevier journal, and I like the OMICS editorial system for handling manuscripts, which is fine. Correspondence has been flawless so far in the past.
14. Your opinion on conducting Editorial Board meetings at related Conferences?
This should always be possible if a relevant number of board members will participate (probably, a more financial support could help)
15. Would you recommend OMICS to your friends or colleagues?
16. How do you differentiate Journal of Diabetes & Metabolism with other journals in the field?
There are certainly several competing journals such as Diabetes Care, Diabetes, Current Diabetes Reports, International Journal of Endocrinology covering aspects in physiology and pathophysiology of diabetes mellitus; Diabetes Technology and Therapy and the Journal of Diabetes Science and Technology are more involved in diabetes technology developments, whereas studies in the areas of diabetes education or the application of novel therapeutic and diagnostic approaches to patients with diabetes mellitus may also be published by the Journal of Diabetes & Metabolism.